These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23440955)

  • 21. Cost-effectiveness analysis of goal-directed hemodynamic treatment of elderly hip fracture patients: before clinical research starts.
    Bartha E; Davidson T; Hommel A; Thorngren KG; Carlsson P; Kalman S
    Anesthesiology; 2012 Sep; 117(3):519-30. PubMed ID: 22814385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of trauma center care.
    MacKenzie EJ; Weir S; Rivara FP; Jurkovich GJ; Nathens AB; Wang W; Scharfstein DO; Salkever DS
    J Trauma; 2010 Jul; 69(1):1-10. PubMed ID: 20622572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capabilities as menus: a non-welfarist basis for QALY evaluation.
    Bleichrodt H; Quiggin J
    J Health Econ; 2013 Jan; 32(1):128-37. PubMed ID: 23202258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate.
    Vera-Llonch M; Massarotti E; Wolfe F; Shadick N; Westhovens R; Sofrygin O; Maclean R; Yuan Y; Oster G
    Rheumatology (Oxford); 2008 Apr; 47(4):535-41. PubMed ID: 18356179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
    Hoerger TJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of improving primary care treatment of late-life depression.
    Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
    Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be?
    Birch S; Gafni A
    J Health Econ; 1992 Oct; 11(3):279-96. PubMed ID: 10122540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On individual preferences and aggregation in economic evaluation in healthcare.
    Liljas B; Lindgren B
    Pharmacoeconomics; 2001; 19(4):323-35. PubMed ID: 11383750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worker replacement and cost-benefit analysis of life-saving health care programs, a precautionary note.
    Tessier P; Sultan-Taïeb H; Barnay T
    Health Econ Policy Law; 2014 Apr; 9(2):215-29. PubMed ID: 24451170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measuring the social importance of concentration or dispersion of individual health benefits.
    Rodríguez-Míguez E; Pinto-Prades JL
    Health Econ; 2002 Jan; 11(1):43-53. PubMed ID: 11788981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethical objections against including life-extension costs in cost-effectiveness analysis: a consistent approach.
    Gandjour A; Müller D
    Appl Health Econ Health Policy; 2014 Oct; 12(5):471-6. PubMed ID: 25027546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness and the socialization of health care.
    Musgrove P
    Health Policy; 1995; 32(1-3):111-23. PubMed ID: 10156632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Welfare properties of restrictions to health care based on cost effectiveness.
    Levaggi L; Levaggi R
    Health Econ; 2011 Jan; 20(1):101-10. PubMed ID: 19946884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness in goal-directed therapy: are the dollars spent worth the value?
    Ebm CC; Sutton L; Rhodes A; Cecconi M
    J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1660-6. PubMed ID: 25479922
    [No Abstract]   [Full Text] [Related]  

  • 38. Endogenous patient responses and the consistency principle in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Med Decis Making; 2012; 32(3):488-97. PubMed ID: 22101019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How many lives is equity worth? A proposal for equity adjusted years of life saved.
    Lindholm L; Rosén M; Emmelin M
    J Epidemiol Community Health; 1998 Dec; 52(12):808-11. PubMed ID: 10396522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
    Stinnett AA; Mullahy J
    Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.